Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice.
暂无分享,去创建一个
M. Donowitz | C. Yun | U. Lehmann | E. Weinman | U. Seidler | H. D. de Jonge | Anurag Kumar Singh | O. Kocher | B. Riederer | B. Hogema | B. Rausch | Janina Bonhagen | Anja Krabbenhöft
[1] M. Donowitz,et al. Defective jejunal and colonic salt absorption and alteredNa+/H+ exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice , 2009, Pflügers Archiv - European Journal of Physiology.
[2] Jin-Xia Zhu,et al. β-Adrenoceptors, but not dopamine receptors, mediate dopamine-induced ion transport in late distal colon of rats , 2008, Cell and Tissue Research.
[3] M. Manns,et al. CFTR and its key role in in vivo resting and luminal acid‐induced duodenal HCO3− secretion , 2008, Acta physiologica.
[4] Ding-zhen Luo,et al. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease , 2008, Neuroscience.
[5] S. Shenolikar,et al. Cystic Fibrosis Transmembrane Conductance Regulator Activation Is Reduced in the Small Intestine of Na+/H+ Exchanger 3 Regulatory Factor 1 (NHERF-1)- but Not NHERF-2-deficient Mice* , 2007, Journal of Biological Chemistry.
[6] M. Zaccolo,et al. Spatiotemporal Coupling of cAMP Transporter to CFTR Chloride Channel Function in the Gut Epithelia , 2007, Cell.
[7] M. Manns,et al. Sodium and chloride absorptive defects in the small intestine in Slc26a6 null mice , 2007, Pflügers Archiv - European Journal of Physiology.
[8] M. Manns,et al. NHE3 inhibition by cAMP and Ca2+ is abolished in PDZ‐domain protein PDZK1‐deficient murine enterocytes , 2007, The Journal of physiology.
[9] Aleksandr Kivenson,et al. Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. , 2007, The Journal of biological chemistry.
[10] M. Manns,et al. Down regulation of small intestinal ion transport in PDZK1- (CAP70/NHERF3) deficient mice , 2007, Pflügers Archiv - European Journal of Physiology.
[11] U. Seidler,et al. The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[12] P. Suh,et al. NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions. , 2006, Biochemical and biophysical research communications.
[13] Paul W Wiseman,et al. Membrane lateral diffusion and capture of CFTR within transient confinement zones. , 2006, Biophysical journal.
[14] W. Guggino,et al. New insights into cystic fibrosis: molecular switches that regulate CFTR , 2006, Nature reviews. Molecular cell biology.
[15] M. Conese,et al. Na+/H+ Exchanger Regulatory Factor Isoform 1 Overexpression Modulates Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Activity in Human Airway 16HBE14o- Cells and Rescues ΔF508 CFTR Functional Expression in Cystic Fibrosis Cells* , 2005, Journal of Biological Chemistry.
[16] D. Callaway,et al. Ezrin Controls the Macromolecular Complexes Formed between an Adapter Protein Na+/H+ Exchanger Regulatory Factor and the Cystic Fibrosis Transmembrane Conductance Regulator* , 2005, Journal of Biological Chemistry.
[17] A. Naren,et al. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners. , 2005, Pharmacology & therapeutics.
[18] Y. Fujiwara,et al. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions , 2005, The Journal of experimental medicine.
[19] P. Aronson,et al. Role of PDZK1 in membrane expression of renal brush border ion exchangers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Lakatta,et al. Heterodimerization of β1- and β2-Adrenergic Receptor Subtypes Optimizes β-Adrenergic Modulation of Cardiac Contractility , 2005 .
[21] W. Thelin,et al. Beyond the brush border: NHERF4 blazes new NHERF turf , 2005, The Journal of physiology.
[22] N. Déliot,et al. NaPi‐IIa and interacting partners , 2005, The Journal of physiology.
[23] M. Donowitz,et al. NHERF family and NHE3 regulation , 2005, The Journal of physiology.
[24] K. Lackner,et al. The CFTR associated protein CAP70 interacts with the apical Cl-/HCO3- exchanger DRA in rabbit small intestinal mucosa. , 2005, Biochemistry.
[25] C. Beglinger,et al. MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT , 2005, Drug Metabolism and Disposition.
[26] K. Dev,et al. Making protein interactions druggable: targeting PDZ domains , 2004, Nature Reviews Drug Discovery.
[27] A. Naren,et al. Molecular Assembly of Cystic Fibrosis Transmembrane Conductance Regulator in Plasma Membrane* , 2004, Journal of Biological Chemistry.
[28] S. Muallem,et al. Gating of CFTR by the STAS domain of SLC26 transporters , 2004, Nature Cell Biology.
[29] A. Verkman,et al. Increased Diffusional Mobility of CFTR at the Plasma Membrane after Deletion of Its C-terminal PDZ Binding Motif* , 2004, Journal of Biological Chemistry.
[30] S. Shenolikar,et al. Localization and interaction of NHERF isoforms in the renal proximal tubule of the mouse. , 2003, American journal of physiology. Cell physiology.
[31] S. Grinstein,et al. The Role of the C Terminus and Na+/H+ Exchanger Regulatory Factor in the Functional Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Nonpolarized Cells and Epithelia* , 2003, Journal of Biological Chemistry.
[32] A. Gilchrist,et al. Targeted Disruption of the PDZK1 Gene by Homologous Recombination , 2003, Molecular and Cellular Biology.
[33] J. Clancy,et al. A macromolecular complex of β2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Cutting,et al. PDZ Domain Interaction Controls the Endocytic Recycling of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2002, The Journal of Biological Chemistry.
[35] M. Gregor,et al. The down regulated in adenoma (dra) gene product binds to the second PDZ domain of the NHE3 kinase A regulatory protein (E3KARP), potentially linking intestinal Cl-/HCO3- exchange to Na+/H+ exchange. , 2002, Biochemistry.
[36] S. Shenolikar,et al. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Bagorda,et al. Reciprocal Protein Kinase A Regulatory Interactions between Cystic Fibrosis Transmembrane Conductance Regulator and Na+/H+ Exchanger Isoform 3 in a Renal Polarized Epithelial Cell Model* , 2002, The Journal of Biological Chemistry.
[38] D. Mak,et al. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[39] W. Guggino,et al. Accessory Protein Facilitated CFTR-CFTR Interaction, a Molecular Mechanism to Potentiate the Chloride Channel Activity , 2000, Cell.
[40] N. Bradbury,et al. E3KARP Mediates the Association of Ezrin and Protein Kinase A with the Cystic Fibrosis Transmembrane Conductance Regulator in Airway Cells* , 2000, The Journal of Biological Chemistry.
[41] G. Cutting,et al. The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. , 2000, The Journal of biological chemistry.
[42] I. Braakman,et al. Regulated trafficking of the CFTR chloride channel. , 2000, European journal of cell biology.
[43] B A Stanton,et al. A PDZ-interacting domain in CFTR is an apical membrane polarization signal. , 1999, The Journal of clinical investigation.
[44] S. Shenolikar,et al. Assembly of signaling complexes by the sodium-hydrogen exchanger regulatory factor family of PDZ-containing proteins. , 1999, Current opinion in nephrology and hypertension.
[45] W. Clauss,et al. Minor Role of Cl– Secretion in Non-Cystic Fibrosis and Cystic Fibrosis Human Nasal Epithelium , 1999, Cellular Physiology and Biochemistry.
[46] S. Beck,et al. Lack of correlation between CFTR expression, CFTR Cl− currents, amiloride‐sensitive Na+ conductance, and cystic fibrosis phenotype , 1999, Pediatric pulmonology.
[47] E. Weinman,et al. The Role of NHERF and E3KARP in the cAMP-mediated Inhibition of NHE3* , 1998, The Journal of Biological Chemistry.
[48] Agnieszka Sidor,et al. NHE3 Kinase A Regulatory Protein E3KARP Binds the Epithelial Brush Border Na+/H+ Exchanger NHE3 and the Cytoskeletal Protein Ezrin* , 1998, The Journal of Biological Chemistry.
[49] M. Welsh,et al. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Knowles,et al. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis. , 1998, American journal of respiratory and critical care medicine.
[51] A. Bakker,et al. Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers. , 1998, American journal of physiology. Cell physiology.
[52] H. Rossmann,et al. A functional CFTR protein is required for mouse intestinal cAMP‐, cGMP‐ and Ca2+‐dependent HCO3− secretion , 1997, The Journal of physiology.
[53] J. Isenberg,et al. Acid-stimulated duodenal bicarbonate secretion involves a CFTR-mediated transport pathway in mice. , 1997, Gastroenterology.
[54] J. Isenberg,et al. CFTR mediates cAMP- and Ca2+-activated duodenal epithelial HCO3- secretion. , 1997, The American journal of physiology.
[55] M. Knowles,et al. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. , 1995, Human gene therapy.
[56] G. Flemström,et al. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. , 1993, Gastroenterology.
[57] S. Szabó,et al. Dopamine in gastrointestinal disease , 1990, Digestive Diseases and Sciences.
[58] E. Lakatta,et al. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. , 2005, Circulation research.
[59] W. Guggino. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins. , 2004, Proceedings of the American Thoracic Society.
[60] S. Shenolikar,et al. Differential renal distribution of NHERF isoforms and their colocalization with NHE3, ezrin, and ROMK. , 2001, American journal of physiology. Cell physiology.
[61] N. Ameen,et al. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract , 2000, Histochemistry and Cell Biology.
[62] F. Collins,et al. Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. , 1994, The Journal of clinical investigation.